Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Recursion Pharmaceuticals Inc (RXRX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Recursion Pharmaceuticals's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
7.48 +0.01    +0.12%
14:26:30 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 1,644,876
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 7.27 - 7.58
Recursion Pharmaceuticals 7.48 +0.01 +0.12%

NASDAQ:RXRX Financials

 
A brief overview of the NASDAQ:RXRX financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Recursion Pharmaceuticals Inc over time.

Recursion Pharmaceuticals, Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was USD 10.62 million compared to USD 13.68 million a year ago. Revenue was USD 10.89 million compared to USD 13.68 million a year ago. Net loss was USD 93 million compared to USD 57.49 million a year ago. Basic loss per share from continuing operations was USD 0.42 compared to USD 0.31 a year ago. Diluted loss per share from continuing operations was USD 0.42 compared to USD 0.31 a year ago.For the full year, sales was USD 43.88 million compared to USD 39.68 million a year ago. Revenue was USD 44.58 million compared to USD 39.84 million a year ago. Net loss was USD 328.07 million compared to USD 239.48 million a year ago. Basic loss per share from continuing operations was USD 1.58 compared to USD 1.36 a year ago. Diluted loss per share from continuing operations was USD 1.58 compared to USD 1.36 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

RXRX Income Statement

Gross margin TTM 4.46%
Operating margin TTM -785.33%
Net Profit margin TTM -735.99%
Return on Investment TTM -57.29%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 10.89 10.53 11.02 12.13
Gross Profit 172.75 -70.35 -53.42 -46.99
Operating Income -98.93 -99.55 -81.72 -68.7
Net Income -93 -93.02 -76.73 -65.33

RXRX Balance Sheet

Quick Ratio MRQ 4.2
Current Ratio MRQ 4.7
LT Debt to Equity MRQ 0.24%
Total Debt to Equity MRQ 10.93%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 653.7 630.82 666.7 627.37
Total Liabilities 190.26 192.86 197.74 197.19
Total Equity 463.44 437.97 468.96 430.18

RXRX Cash Flow Statement

Cash Flow/Share TTM -1.33
Revenue/Share TTM 0.21
Operating Cash Flow  -79.51%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities -74.08 -72.92 -67.47 -73.32
Cash From Investing Activities -2.49 -0.347 -2.05 -5.34
Cash From Financing Activities 80.66 53.76 3.79 1.92
Net Change in Cash 4.22 -19.62 -65.55 -76.74
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

RXRX Comments

Write your thoughts about Recursion Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Charlie Charlie Charlie
Charlie Charlie Charlie Apr 16, 2024 5:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
at the edge of rising or descending.
Neil Young
Neil Young Feb 26, 2024 5:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Strong Buy
upticks boombust
upticks boombust Feb 15, 2024 1:56AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Going bankrupt
shawn mimnaugh
shawn mimnaugh Dec 14, 2023 1:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Anyone have any news to support this uptick in price, volume?
Mary Hill
Mary Hill Aug 09, 2023 9:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Watch it climb up 🚀
Mary Hill
Mary Hill Aug 07, 2023 11:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Don't underestimate nvidia partnership! $100 soon
Mary Hill
Mary Hill Aug 07, 2023 11:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nvidia partnership 👏
Jul 12, 2023 6:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Rubish
ONUR YILDIRIM
ONUR YILDIRIM Jul 12, 2023 9:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What da hell happened this?
SEOK D
SEOK D May 23, 2022 9:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
SCAM
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email